We want to share the acknowledgment that APICES has received in a rectal cancer phase II trial in the recent paper published in American Journal of Clinical Oncology, in which APICES has collaborated in data management, statistical analysis, and…
We want to share the acknowledgment that APICES has received in a hereditary cancer study in the recent paper published in Hereditary Cancer in Clinical Practice journal, in which APICES has collaborated in medical writing activities. This means a…
In the challenging clinical research world, some milestones celebrate dedication and commitment. This year, APICES, a leading company in the sector, proudly commemorates its 15th anniversary. Since its inception, APICES has been an internationally renowned CRO, recognized for…
The ESMO 2024 congress in Barcelona united the global Oncology community to discuss the latest breakthroughs in cancer research. APICES, as a CRO with 15 years of experience in Oncology clinical trials, we were honored to be part…
We want to share the acknowledgment that APICES has received in the EBANO in the recent paper published in ESMO Real World Data and Digital Oncology journal, in which APICES has collaborated in protocol medical writing, start-up, project management,…
APICES has received an acknowledgment in Urothelial Carcinoma in Clinical and Translational Oncology Journal
Our team at APICES CRO will be attending the ESMO Congress 2024 in Barcelona from September 13th to 17th!
Acknowledgment for APICES collaboration in RE-SERARCH study (Clinical and Translational Oncology)
The Spanish Agency for Medicines and Health Products (AEMPS) has expanded its accelerated evaluation process (fast-track), including bioequivalence studies. Interested sponsors must contact AEMPS before submitting the application to benefit from this process. This email should include the…
This month, we want to share the acknowledgment that APICES has received in the recent publication of LOADH Study: Treatment adherence to oral chemotherapy in patients with locally advanced or metastatic small cell lung cancer: protocol for a…
